ADVERTISEMENT

Buy, Sell Or Hold: LIC, Piramal Pharma, Mamaearth, Tata Power, Titagarh Rail Systems — Ask Profit

Market analysts share insights for short-term and long-term investors on whether to buy, sell or hold shares of LIC, Tata Power, Hyundai Motors, Mamaearth, and Piramal Pharma, among others.

<div class="paragraphs"><p>Mahesh Ojha of Hensex Securities and Rajesh Bhosale of Angel One share their insights on  Piramal Pharma, Mamaearth, Tata Power, Titagarh Rail Systems, and other stocks on NDTV Profit's&nbsp;<em>Ask Profit</em> show.<br>(Representative image. Photo source: Pexels)</p></div>
Mahesh Ojha of Hensex Securities and Rajesh Bhosale of Angel One share their insights on Piramal Pharma, Mamaearth, Tata Power, Titagarh Rail Systems, and other stocks on NDTV Profit's Ask Profit show. (Representative image. Photo source: Pexels)

Should you buy shares of Life Insurance Corporation of India and Titagarh Rail Systems Ltd. at the current price? Are Piramal Pharma Ltd. and Tata Power Co. good choices from a long-term perspective? Should you keep holding Mamaearth-parent Honasa Consumer Ltd. and Garden Reach Shipbuilders & Engineers Ltd.? Is it the right time to exit Sterling and Wilson Ltd. to book profit?

Mahesh Ojha, assistant vice president for research and development at Hensex Securities Pvt. and Rajesh Bhosale, technical analyst at Angel One Ltd., answered these investor queries and more on NDTV Profit's Ask Profit show.

Tata Power (Current Market Price: Rs 433.55)

Bhosale: Hold

  • For now, the momentum is a bit gradual and a stiff resistance is seen at around Rs 445 to Rs 450 levels.

  • Once this level is crossed, then we can expect more momentum which can take the stock towards Rs 500 level.

LIC (CMP: Rs 928.50)

Ojha: Hold

  • We are extremely bullish on insurance sector.

  • Optimistic for the stock, with a target of Rs 1,150-1,200 levels.

  • I suggest a long-term hold on the stock.

Opinion
November 2024 Sees Rise In Private APE; LIC APE Impacted By Weak Group Single Premiums: CareEdge

Piramal Pharma (CMP: Rs 251.80)

Ojha: Hold

  • The stock is set for a long-term growth story.

  • If you view is for 9-12 month horizon, the target is around Rs 325-350.

  • But, if your view is for more than two years, the target is at Rs 400-plus level.

Titagarh Rail Systems (CMP: Rs 1,333.60)

Ojha: Buy

  • We may see Rs 1,450 to Rs 1,500 plus levels in upcoming time for the stock.

  • One should add the stock in a staggered manner.

  • Downside of Rs 1,150 to Rs 1,200 levels is the best price to add more.

Hyundai Motors (CMP: Rs 1,798)

Ojha: Hold

  • One can hold the stock.

  • For two-year perspective, the target will be around Rs 2,000-Rs 2,300 plus levels.

Opinion
Hyundai Motor Gets 'Add' As Kotak Equities Initiates Coverage, Sees 11% Upside

Garden Reach Shipbuilders (CMP: Rs 1,170.15)

Bhosale: Hold

  • As of now, the short-term momentum is on the positive side.

  • Hold on for Rs 2,100 level.

Honasa Consumer (CMP: Rs 250.85)

Ojha: Hold for short term

  • After Q2 results, the stock has seen lower circuits for some time.

  • We expect Rs 310-320 levels to come at three to six months.

  • Hold the stock for short-term.

  • Not optimistic for long-term.

Strides Pharma (CMP: Rs 706.05)

Bhosale: Hold

  • Overall, the chart structure looks positive.

  • The stop loss will always be around Rs 650.

  • In the near term, the stock is headed towards Rs 850-880 levels.

Sterling & Wilson (CMP: Rs 489.10)

Bhosale: Hold and exit on a bounce

  • Hold on to the stock for now.

  • The stop loss can be at around Rs 465-475 levels.

  • After bounce back, the stock will see stiff resistance at around Rs 590-600 levels.

Bosch (CMP: Rs 36,284.6)

Bhosale: Hold.

  • The stock is gradually moving upwards and the overall chart structure remains positive.

  • Somewhere around Rs 38,000, we might see some negative diversions. That will be the best time to book profit.

Watch Full Episode Here:

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.

OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit